Medpacto Reveals Four Studies in AACR, U.S.

Medpacto Reveals Four Studies in AACR, U.S. [April 4, 2021] Medpacto (CEO Seong-Jin Kim) announced on the 12th that it has published four research results in the American Association for Cancer Research (AACR). Medpacto conducted preclinical results of Vactosertib-ONIVYDE/5-FU/LV combination therapy for pancreatic cancer at AACR 2021 held online, 2 cases of Vactosertib follow-up pipeline (BAG2, DRAK1) and TGF-β biomarker analysis in desmoid tumors. A total of 4 research results including the results were published. The first presentation relates to the combination therapy of Vactosertib-ONIVY..........

원문링크 : Medpacto Reveals Four Studies in AACR, U.S.